Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Endocrinology (Baltimore, Md.)|May 21, 2013
Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acidsBrian D Hudson, Hannah Murdoch, Graeme Milligan
The British Journal of Nutrition|January 3, 2014
G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targetsGraeme Milligan, Trond Ulven, Hannah Murdoch, et al.
The Journal of Biological Chemistry|December 14, 2004
Periplakin interferes with G protein activation by the melanin-concentrating hormone receptor-1 by binding to the proximal segment of the receptor C-terminal tailHannah Murdoch, Gui-Jie Feng, Dietmar Bächner, et al.
Molecular Pharmacology|May 30, 2014
Complex pharmacology of novel allosteric free fatty acid 3 receptor ligandsBrian D Hudson, Elisabeth Christiansen, Hannah Murdoch, et al.
Journal of Cell Science|June 10, 2011
Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein functionHannah Murdoch, Suryakiran Vadrevu, Anke Prinz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2007
Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levelsHannah Murdoch, Shaun Mackie, Daniel M Collins, et al.
Cellular Signalling|October 11, 2008
Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA)Daniel M Collins, Hannah Murdoch, Allan J Dunlop, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2007
PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6)York-Fong Cheung, Zhengyan Kan, Philip Garrett-Engele, et al.
The Journal of Physiology|September 8, 2007
Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illnessJ Kirsty Millar, Shaun Mackie, Steven J Clapcote, et al.
The Journal of Biological Chemistry|April 17, 2013
Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptorBrian D Hudson, Maria E Due-Hansen, Elisabeth Christiansen, et al.
Pageof 2